GSA Capital Partners »

Allogene Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $66k 21k 3.22
2023-09-30 $402k 127k 3.17
2022-12-31 $1.6M 251k 6.29
2022-09-30 $344k 32k 10.80
2022-03-31 $1.4M 149k 9.11
2021-12-31 $1.7M 115k 14.92
2021-06-30 $364k 14k 26.09
2020-12-31 $285k 11k 25.28
2019-12-31 $276k 11k 25.98